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Abstract  
 
Objective 
To determine whether antioxidants supplements and antioxidant-enriched 
foods can prevent or reduce delayed onset muscle soreness after exercise.  
 
Methods 
We searched the Cochrane Bone, Joint and Muscle Trauma Group 
Specialised Register, the Cochrane Central Register of Controlled Trials, 
MEDLINE, Embase, SPORTDiscus, trial registers, reference lists of articles 
and conference proceedings up to February 2017 
 
Results 
In total, 50 studies were included in this review which included a total of 
1089 participants (961 were male and 128 were female) with an age range 
between 16 and 55 years. All studies used an antioxidant dosage higher 
than the recommended daily amount. The majority of trials (47) had design 
features that carried a high risk of bias due to selective reporting and 
poorly described allocation concealment, potentially limiting the reliability 
of their findings. We rescaled to a 0 to 10 cm scale in order to  quantify the 
actual difference between groups and we found that the 95% CIs for all five 
follow-up times were all well below the minimal important difference of 1.4 
cm: up to 6 hours (MD -0.52, 95% CI -0.95 to -0.08); at 24 hours (MD -0.17, 
95% CI -0.42 to 0.07); at 48 hours (MD -0.41, 95% CI -0.69 to -0.12); at 72 
hours (MD -0.29, 95% CI -0.59 to 0.02); and at 96 hours (MD -0.03, 95% CI - 
0.43 to 0.37). Thus, the effect sizes suggesting less muscle soreness with 
antioxidant supplementation were very unlikely to equate to meaningful or 
important differences in practice. 
 
Conclusions 
There is moderate to low-quality evidence that high dose antioxidant 
supplementation does not result in a clinically relevant reduction 
of muscle soreness after exercise at up to 6 hours or at 24, 48, 72 and 96 
hours after exercise. There is no evidence available on subjective recovery 
and only limited evidence on the adverse effects of taking antioxidant 
supplements. 
  
Introduction  1 
 2 
 Delayed onset muscle soreness (DOMS) typically occurs after 3 
strenuous and unaccustomed exercise and physical activity. It is classified 4 
as a grade 1 muscle strain injury and is characterised by localised 5 
tenderness and soreness.1 Depending on the severity of exercise, DOMS 6 
typically peaks between 24 to 72 hours after a bout of exercise but 7 
eventually disappears after five to seven days.2-7 DOMS could be 8 
detrimental for athletes who are returning to training from a prolonged 9 
period of inactivity. In addition, DOMS could deter individuals from 10 
adhering to an exercise programme. For some individuals, DOMS could 11 
result from excessive physical activity associated with daily living, 12 
particularly if repeated eccentric movements or unaccustomed physical 13 
activity are involved.  14 
 15 
 Several theories have been proposed to explain the mechanisms 16 
underlying DOMS. These include lactate accumulation,8 inflammation,9 17 
muscle spasm,10 muscle damage,11 connective tissue damage,12and 18 
increased muscle temperature.13 A common feature of several of these 19 
proposed mechanisms is an increased production of free radicals,14 and 20 
reactive oxygen species. Indeed, it has been shown that reactive oxygen 21 
species are produced in nearly every biological process and that they also 22 
play a crucial role as signalling molecules for translating the exercise signals 23 
to appropriate adaptations.15  24 
 25 
 The rationale for taking antioxidant supplements after exercise to 26 
reduce DOMS comes from the notion that they could reduce the negative 27 
effects of reactive oxygen species and oxidative stress resulting from 28 
exercise.16 Oxidative stress could deplete the body's antioxidant defences 29 
and increase the rate of free radical production.17-19 Moreover, 30 
unaccustomed, eccentric and exhaustive exercise may also induce 31 
inflammatory reactions which can contribute to increased reactive oxygen 32 
species production and reduced antioxidant defences.20 These can cause 33 
exercise-induced muscle damage and result in DOMS.1 Dietary antioxidants 34 
may counteract oxidative stress by reducing the production of free radical 35 
and reactive oxygen species associated with exercise.17 Reducing DOMS 36 
could be beneficial to athletes when returning to training from injury (i.e. 37 
after a period of inactivity), and it could help sedentary and older 38 
individuals recover from unaccustomed physical activity.  39 
 40 
 The ease of taking antioxidant supplements to prevent and reduce 41 
muscle soreness after exercise and enhance recovery makes it an attractive 42 
option for physically active individuals. Moreover, antioxidant supplements 43 
are available to buy from supermarkets and health food stores and some 44 
are marketed to enhance recovery. Despite the popularity of antioxidant 45 
supplements, the evidence supporting its used is mixed.21-23 Therefore, the 46 
objective of this systematic review was to determine whether antioxidant 47 
supplements and antioxidant-enriched foods could prevent or reduce 48 
DOMS after exercise.  49 
   50 
  51 
 52 
 53 
  54 
Methods 55 
 56 
 Inclusion criteria 57 
 58 
 Any randomised controlled trials or quasi-randomised controlled 59 
trials investigating the effects of dietary antioxidants on preventing or 60 
reducing delayed onset muscle soreness were considered for this meta-61 
analysis. 62 
 63 
 Search strategy 64 
 65 
 A systematic search of the literature was conducted in the 66 
Cochrane Bone, Joint and Muscle Trauma Group Specialised Register, the 67 
Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, 68 
Embase and SPORTDiscus, current to February 2017 was performed by two 69 
authors. ClinicalTrials.gov and the World Health Organization Clinical Trials 70 
Registry Platform were also searched for any ongoing or recently 71 
completed studies. Experts in the field were also contacted to find 72 
unpublished trials. The reference list of all included studies and relevant 73 
reviews were also screened for further references to relevant trials. No 74 
language restrictions were applied. 75 
 76 
 Data extraction 77 
 78 
 Two authors independently extracted data using a customised form. 79 
We resolved any disagreements by consultation with the other authors. In 80 
some cases, the primary authors of selected studies were contacted for 81 
additional information and data. 82 
 83 
 Heterogeneity and risk of bias 84 
 For all included studies, methodologic quality was assessed by two 85 
authors independently, using the Cochrane risk of bias tool.24 We resolved 86 
any disagreement by discussion and, if necessary, consultation with the 87 
other authors. Heterogeneity was assessed using the Chi² test and I² 88 
statistic, with the level of significance for the Chi² test being set at P = 0.1.25 89 
We interpreted values of I² as follows: might not be important (0% to 40%); 90 
may represent moderate heterogeneity (30% to 60%); may represent 91 
substantial heterogeneity (50% to 90%); and may represent considerable 92 
heterogeneity (75% to 100%). 93 
 94 
 Meta-analyses 95 
 96 
 Mean differences with 95% confidence intervals were calculated 97 
for continuous data using RevMan (Review Manager; RevMan). When 98 
studies used different ways of measuring a continuous outcome 99 
standardised mean differences and 95% confidence intervals were 100 
calculated. Due to substantial clinical and statistically significant 101 
heterogeneity a random-effects model, again with 95% confidence intervals, 102 
was employed. 103 
 104 
 Subgroup analyses 105 
 106 
 Subgroup analyses were performed in RevMan. Subgroup analyses 107 
included the timing of anti-oxidant administration (pre-exercise versus 108 
post-exercise), type of exercise (mechanically induced damage versus 109 
whole body aerobic exercise), and funding source (trials funded by food 110 
company or provider of antioxidant supplements versus those not funded 111 
by food company or provider of antioxidant supplements). 112 
  113 
Results 114 
 115 
 Study Characteristics  116 
 117 
 We completed the search in February 2017 and 1558 records from 118 
the following databases were screened: Cochrane Bone, Joint and Muscle 119 
Trauma Group Specialised Register (25 records), CENTRAL (194),MEDLINE 120 
(302), Embase (476), SPORTDiscus (117), ClinicalTrials.gov (162) and the 121 
WHO International Clinical Trials Registry Platform (282). We also identified 122 
12 potentially eligible studies from ongoing searches and through 123 
contacting experts in the field. The search resulted in the identification of 124 
128 potentially eligible studies, for which we obtained full reports. Upon 125 
study selection, we included 50 and excluded 77. 126 
 127 
 The 50 trials included in this systematic review had a total of 1089 128 
participants with 901 participants in the parallel-group trials (range 7 to 54) 129 
and 188 participants in the cross-over trials (range 8 to 24). All 50 studies 130 
were randomised controlled trials; no quasi-randomised controlled trials 131 
met the inclusion criteria. Thirty-eight trials (with a total of 901 132 
participants) employed a parallel design.21,22,26-59 The other 12 trials (with a 133 
total of 188 participants) employed a cross-over design. 60-71 134 
 135 
 Seven trials were designed to produce DOMS under field-based 136 
conditions,22,34,43-45,63 and the other 43 studies were designed to produce 137 
DOMS under laboratory-based conditions. In all trials, an antioxidant 138 
supplement was compared with a placebo. Thirteen trials used antioxidants 139 
from a whole natural food source, 22,28,29,40,43,45,50,61,63,64,67,70,71 19 used an 140 
antioxidant extract or mixed 141 
antioxidants,26,31,34,36,37,39,41,42,44,47,48,51,52,54,60,65,66,68 and 18 provided either 142 
vitamin C or vitamin E or both together.21,27,30,32,33,35,38,46,49,53,55,57-59,62,69,72,73 143 
All studies used a placebo either as a powder, capsule or drink; however, 144 
three studies did not provide details of what the placebo comprised.46,49,60 145 
No trials compared high-dose versus low-dose antioxidant supplements, 146 
where the low-dose supplementation is within normal or recommended 147 
levels for the antioxidant involved. 148 
 149 
 There was a large variation across the studies regarding the 150 
duration of supplementation: the shortest period was under one day68,69 151 
and the longest period was 91 days.39 Although the form of supplement 152 
was varied, including capsules, powders and drinks, every study used an 153 
antioxidant dosage higher than the recommended daily amount. Every 154 
study required the participant to ingest the supplement orally either once 155 
daily or up to three times per day. Supplementation was taken before, the 156 
day of and after exercise for up to several days in all the studies except for 157 
three studies where supplements were post-exercise only.65,67,74  158 
 159 
 Funding 160 
 161 
 In all, 21 studies were industry funded either by a food company or 162 
a provider of antioxidant supplements. 26-29,31,32,39,41,43,47,50,52,58,60,61,67-71,73 Of 163 
the 28 other studies reporting on funding, 15 declared “none” in their 164 
report;21,30,33-36,40,44,46,49,53,57,59,62 the other 13 referring to various sources of 165 
university and public body research funding sources.22,37,38,42,45,48,51,54,55,63-66 166 
We were unsuccessful in obtaining information on funding from the only 167 
trial that did not report on this.56  168 
 169 
 Risk of Bias 170 
Forty-seven trials (94%) had design features that were deemed to carry a 171 
high risk of bias due to random sequence generation (19 trials),21,22,27,35,37,41-172 
43,46,49,52,56,57,60,61,65,66,70,71 selective reporting (41 trials),21,22,26-33,35-40,42,46-49,51,53-173 
63,66-73 poorly described allocation concealment (30 trials), 21,22,27,35-174 
37,40,42,43,45-47,49,51-53,56,58-62,64,65,68-73 attrition bias (12 trials),32,40,42,45,47,52,54,55,60-175 
62,65 and lack of dietary monitoring during the intervention (16 trials), 176 
26,29,31,42,46,49,53-55,57,59,63-66,69 potentially limiting the reliability of their findings. 177 
  178 
 179 
 Primary Outcomes 180 
 All of the 50 trials included in this review measured muscle 181 
soreness, however, there were differences in the types of soreness scales 182 
used. Thirty-three trials measured muscle soreness using a 0 to 10 cm (or 0 183 
to 100 mm) visual analogue scale (VAS). Of the 17 other trials, seven65,75-80 184 
measured soreness using a 1 to 10 cm scale; four trials29,45,81,82 used the 0 to 185 
20 cm (or 0 to 200 mm) scale; two studies38,48 used a 0- to 6-point scale, 186 
Herrlinger39 used a 0 to 7 Likert scale, Drobnic36 used a 0- to 4-point scale; 187 
Cobley34 used a 0 to 12 cm scale and Su56 used the Borg CR-10 scale. The 188 
Borg CR-10 scale ranges from 0 (no soreness) to 10 (maximal soreness). In 189 
the included studies, participants were asked to rate muscle soreness on 190 
the soreness scales by either carrying out a squat using body weight, self-191 
palpitation of muscle or based on muscle soreness at rest. 192 
 193 
 Forty-eight studies presented data on muscle soreness at various 194 
different time points based on various visual analogue scale (VAS) scores. 195 
Results are presented at eight follow-up times after exercise: up to 6 hours, 196 
and at 24, 48, 73, 96, 120, 144 and 168 hours. 197 
 198 
 Antioxidant supplementation reduced muscle soreness in 199 
comparison to the placebo condition when measured up to 6 hours post- 200 
exercise (standardised mean difference (SMD) -0.30, 95% confidence 201 
interval (CI) -0.56 to -0.04; participants = 525; studies = 21; I2 = 53%; low-202 
quality evidence);  at 24 hours after exercise (SMD -0.13, 95% CI -0.27 to 203 
0.00; participants = 936; studies = 41; I2 = 5%; moderate-quality evidence);  204 
at 48 hours after exercise (SMD -0.24, 95% CI - 0.42 to -0.07; participants = 205 
1047; studies = 45; I2 = 47%; low quality evidence); and at 72 hours after 206 
exercise (SMD -0.19, 95% CI -0.38 to -0.00; participants = 657; studies = 28; 207 
I2 = 27%; moderate-quality evidence). There was little effect of antioxidants 208 
on muscle soreness at 96 hours after exercise (SMD -0.05, 95% CI -0.29 to 209 
0.19; participants = 436; studies = 17; I2 = 31%; low-quality evidence). Far 210 
fewer trials provided data at five days or subsequently. There was very low-211 
quality evidence of little effect of antioxidants on muscle soreness at 120 212 
hours (SMD 0.21, 95% CI -0.26 to 0.69; participants = 128; studies = 4; I2 = 213 
39%), at 144 hours (SMD -0.23, 95% CI -1.11 to 0.65; participants = 20; 214 
studies = 1) or at 168 hours (SMD - 0.04, 95% CI -0.48 to 0.41; participants = 215 
80; studies = 4; I2 = 0%). 216 
 217 
 As there was considerable variation in the units used to measure 218 
muscle soreness, we rescaled all trials to the 0 to 10 scale at the first five 219 
time points in order to explore the actual difference between groups on a 220 
standard scale. The results are as follows: up to 6 hours (mean difference 221 
(MD) -0.52, 95%CI -0.95 to -0.08; participants = 525; studies = 21; I2 = 66%); 222 
at 24 hours (MD - 0.17, 95% CI -0.42 to 0.07; participants = 936; studies = 223 
41; I2 = 29%); at 48 hours (MD -0.41, 95% CI -0.69 to - 0.12; participants = 224 
1047; studies = 45; I2 = 64%); at 72 hours (MD -0.29, 95% CI -0.59 to 0.02; 225 
participants = 657; studies = 28; I2 = 27%); and at 96 hours (MD-0.03, 95% 226 
CI -0.43 to 0.37; participants = 436; studies = 17; I2 = 51%). This rescaling 227 
also allows us to examine whether the antioxidant supplement produces a 228 
clinically important difference. For consistency with Bleakley,4 we 229 
considered 1.4 cm as the minimal important difference (MID) for pain 230 
reduction on a 10 cm visual analogue scale; this was based on an estimated 231 
MID for musculoskeletal conditions of the shoulder by Tashjian.83 It is 232 
notable that all of the upper limits of the 95% CIs of these five analyses are 233 
lower than this MID and hence all quantitative differences do not appear to 234 
represent person-relevant differences in muscle soreness. 235 
 236 
 Subgroup and sensitivity analyses  237 
 238 
 We performed only a few subgroup and sensitivity analyses. We 239 
selected the 24 and 48 hours analyses for subgroup analyses given that 240 
these were the categories with the largest number of trials. We did not use 241 
the up to 6 hours time period because of the variation in the timing of 242 
measurement: i.e. some studies measured this outcome immediately after 243 
exercise whereas other studies measured this up to 2 hours or up to 6 244 
hours after exercise. A sensitivity analysis exploring the use of the fixed-245 
effect model for all eight follow-up times produced similar results to that of 246 
random-effects model. A subgroup analysis could not be performed on 247 
timing of administration (i.e. pre-exercise and post-exercise versus post-248 
exercise only) because there were very few trials (one or two studies 249 
depending on the time of follow-up) in the post-exercise group. We 250 
performed a subgroup analysis on the type of exercise, that is, mechanically 251 
induced versus whole body aerobic exercise for the 24 and 48 hour follow-252 
up times. There is no evidence of subgroup differences for muscle soreness 253 
for type of exercise at 24 hours (Chi² = 0.44, df = 1; P = 0.51, I² = 0%) or at 254 
48 hours (Chi² = 0.88, df = 1; P = 0.35, I² = 0%). Our second subgroup 255 
analysis was based on source of funding where we compared studies that 256 
were funded by a food company or provider of antioxidant supplements 257 
versus studies that there were not. There is no evidence of subgroup 258 
differences for muscle soreness according to source of funding at 24 hours 259 
(Chi² = 0.03, df = 1, P = 0.87, I² = 0%) or 48 hours (Chi² = 0.10, df = 1, P = 260 
0.875 I² = 0%); no information on funding was available for Su.56 261 
 262 
 We conducted a sensitivity analysis testing trials at unclear risk of 263 
bias, relating to random sequence generation, allocation concealment or 264 
both, which included 19 trials.22,26,28-34,38,39,44,48,50,54,55,63,67,68 This analysis 265 
made little difference to the overall effect at either 24 hours post-exercise 266 
(SMD -0.10, 95% CI -0.37 to 0.17; participants = 280; studies = 14; I2 = 19%) 267 
or at 48 hours (SMD -0.31, 95% CI -0.66 to 0.04; participants = 327; studies 268 
= 16; I2= 57%). 269 
 270 
 Subjective Recovery  271 
No study measured subjective recovery (return to previous activities 272 
without signs or symptoms). 273 
 274 
 Adverse effects 275 
 276 
 Nine studies34,41,43-45,50,52,64,65 reporting on a total of 216 participants, 277 
reported on this outcome (very low-quality evidence). One study reported 278 
that all six participants in the NAC (N-acetylcysteine) supplementation 279 
group had diarrhoea, which was mild in five participants and severe 280 
diarrhoea in one.34 The same study reported mild indigestion in four 281 
participants (67%) in the NAC group and one of six participants in the 282 
placebo group. Another study43 reported that tart cherry juice caused mild 283 
gastrointestinal distress in one of 26 participants taking the antioxidant 284 
supplement. Seven studies reported no adverse effects of taking the 285 
antioxidant supplementation.41,44,45,50,52,64,65 The remaining 41 studies failed 286 
to report adverse effects. 287 
  288 
Discussion  289 
 This review examined the effectiveness of antioxidants for 290 
preventing and treating muscle soreness after exercise. Fifty randomised 291 
placebo-controlled studies were included, 12 of which used a crossover 292 
design. The 50 studies involved a total of 1089 participants (961 male; 128 293 
female; age range 16 to 55 years). The studies were heterogeneous, 294 
including the timing (pre-exercise or post exercise), frequency, dose or 295 
duration, and type of antioxidant supplementation, and the type of 296 
preceding delayed onset muscle soreness (DOMS)-producing exercise. All 297 
studies used an antioxidant dosage higher than the recommended daily 298 
amount. No studies compared high-dose versus low-dose, where the low-299 
dose supplementation was within normal or recommended levels for the 300 
antioxidant involved. 301 
 302 
 Pooled standardised mean difference (SMD) results for muscle 303 
soreness indicated a small difference in favour of antioxidant 304 
supplementation after DOMS-inducing exercise at all main follow ups (up to 305 
6 hours; low-quality evidence, at 24 hours; moderate-quality evidence, at 306 
48 hours; low-quality evidence, at 72 hours; moderate- quality evidence, at 307 
96 hours; low-quality evidence. When, however, we rescaled all the trial 308 
results to the 0 to 10 cm scale in order to compare the actual difference 309 
between groups, we found that the 95% confidence intervals (CIs) for all 310 
five follow up times were all below 1.0 cm, and thus all below the minimal 311 
important difference of 1.4 cm that we used in this review. Thus, all 312 
statistical differences in DOMS favouring antioxidant supplementation were 313 
unlikely to equate to meaningful or important differences in practice. 314 
 315 
 Neither of our subgroup analyses to examine for differences in 316 
effect according to type of DOMS-inducing exercise (mechanical versus 317 
whole body aerobic) or according to funding source confirmed subgroup 318 
differences. Sensitivity analyses to test the selection of the statistical model 319 
for pooling (fixed-effect instead of random effects) and the exclusion of 320 
cross-over studies all showed similar results to the main analyses. None of 321 
the 50 studies reported on subjective recovery (return to previous activities 322 
without signs or symptoms). Only nine studies (216 participants) reported 323 
on adverse effects, with actual events reported in two studies. One study34 324 
(12 participants) reported that all six participants in the NAC (N-325 
acetylcysteine supplementation group had diarrhoea, which was mild in 326 
five participants and severe in one. The same study34 reported mild 327 
indigestion in four participants (67%) in the NAC group and one of six 328 
participants in the placebo group. It should be noted that NAC 329 
supplementation is usually prescribed and it has been found to cause 330 
uncomfortable side effects including nausea and diarrhoea in other studies. 331 
Another study43 reported that tart cherry juice caused mild gastrointestinal 332 
distress in one of 26 participants taking the antioxidant supplement. The 333 
other seven studies reported no adverse effects of taking the antioxidant 334 
supplementation; this included 10 participants having NAC 335 
supplementation in one study. Overall, the available evidence for adverse 336 
events is very low-quality. 337 
 338 
 The majority of the 1089 participants included in this review were 339 
male (961; 88.2%) and so arguably the findings of the review are mainly 340 
applicable to males but there is no biological basis for why antioxidants 341 
should have a different effect in the two sexes. These sex differences are 342 
typical of what is observed in the athletic recovery literature.3,4,7 More 343 
noteworthy is that no data from highly-trained elite athletes were included 344 
in the analyses; the data pertaining to nine elite athletes tested in 345 
McCormick63 were not included in the meta-analyses because the exercise 346 
paradigm was completely different to all the other studies included in this 347 
review. As the majority of the participants were either college students or 348 
relatively young and active, these findings cannot be generalised in the elite 349 
athlete population who have a different physiological and training status. 350 
Some reservations in terms of applicability also apply to older individuals 351 
due to their anatomical and physiological characteristics as there were no 352 
older participants included in this review (age range of participants: 16 to 353 
55 years). 354 
 355 
 We assessed the quality of evidence using the GRADE framework, 356 
which combines considerations of risk of bias, indirectness, inconsistency 357 
(heterogeneity), imprecision and publication bias. We downgraded all 358 
outcomes one level for serious risk of bias, due mainly to selective 359 
reporting bias (the majority of the trials failed to report on adverse effects) 360 
and, to a lesser degree, attrition biases. We did not downgrade for 361 
indirectness in relation to muscle soreness. We downgraded two outcomes 362 
for serious inconsistency reflecting heterogeneity that could not be traced 363 
to the inclusion of just one outlier trial. Pooled evidence did not support 364 
downgrading for imprecision. Our tests for publication bias did not reveal a 365 
serious concern, although all were small studies. Thus, we did not 366 
downgrade for publication bias. We concluded that the quality of the 367 
evidence ranged from moderate to very low. 368 
 369 
 It is important to acknowledge some important limitations of this 370 
review. Firstly, data from 14 studies21,27,35,37,42,47,52,56,60,61,65,67,70,71 were 371 
extracted from graphs using Graphclick 2010 Arizona (version 3.0.2, 2010) 372 
because the authors did not respond to several emails requested mean and 373 
SD data. Whilst this is not ideal, we tried to minimise error by having two 374 
review authors (MR and DR) independently extract the data, with any 375 
discrepancies resolved by consultation with the third and fourth authors 376 
(HS and JC). Secondly, our inclusion of cross-over studies and our analysis of 377 
their data as if from a parallel group trial, thus without adjustment for the 378 
cross-over design, are other potential sources of bias. With one exception, 379 
the cross-over studies included in this review used a washout period of two 380 
to six weeks, which is sufficient to allow the muscles to recover. The 381 
exception60 used a washout period of only five days between treatments 382 
and therefore carries some risk of a carry-over effect; sensitivity analysis to 383 
check on the effect of excluding the data from this trial did not result in 384 
important changes. Further sensitivity analyses checking the effects of 385 
excluding the cross-over trials from the muscle soreness analyses showed 386 
that our inclusion and handling of the cross-over studies did not have an 387 
important impact on the review results. 388 
 389 
 390 
Conclusions  391 
 392 
 There is moderate- to low-quality evidence that antioxidant 393 
supplementation does not result in a clinically relevant reduction of DOMS 394 
after exercise at any of the five follow-up times assessed (up to 6 hours and 395 
at 24, 48, 72 and 96 hours after exercise. There is no evidence available on 396 
subjective recovery and only limited evidence on adverse effects of taking 397 
antioxidant supplements. Some antioxidant supplements such as N-398 
acetylcysteine may cause unwanted side effects including gastrointestinal 399 
discomfort and diarrhoea. Thus, taking antioxidants supplements and 400 
antioxidant-enriched foods is not an effective strategy to reduce DOMS 401 
after exercise.  402 
 403 
What is already known? 
Taking antioxidants supplements to reduce muscle soreness is a common 
strategy used by recreational and elite athletes. However, little is known 
about how effective antioxidants are at reducing delayed onset muscle 
soreness.  
What are the new findings? 
 There is moderate to low-quality evidence that high dose 
antioxidant supplementation does not result in a clinically relevant 
reduction of muscle soreness after exercise at up to 6 hours or at 
24, 48, 72 and 96 hours after exercise. 
 There is no evidence available on subjective recovery and only 
limited evidence on the adverse effects of taking antioxidant 
supplements.  
 The findings of, and messages from, this review provide an 
opportunity for researchers and other stakeholders to come 
together and consider what are the priorities, and underlying 
justifications, for future research in this area. 
 404 
 405 
 406 
  407 
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